ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

SGMT Sagiment Biosciences Inc

4,07
-0,15 (-3,55%)
19 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Sagiment Biosciences Inc SGMT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,15 -3,55% 4,07 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,20 3,92 4,26 3,95 4,22
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.6.202412:07EDGAR2Form 8-K/A - Current report: [Amend]
07.6.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202412:03EDGAR2Form 8-K - Current report
23.5.202413:00EDGAR2Form 8-K - Current report
15.5.202414:05EDGAR2Form 8-K - Current report
15.5.202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.5.202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.5.202414:06EDGAR2Form 8-K - Current report
25.3.202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
25.3.202411:15GLOBESagimet Biosciences Reports Full Year 2023 Financial Results..
29.2.202414:00GLOBESagimet Biosciences to Participate in Two Upcoming Investor..
15.2.202400:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202422:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05.2.202422:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.2.202422:36EDGAR2Form 8-K - Current report
02.2.202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.1.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202422:05EDGAR2Form 8-K - Current report
26.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26.1.202402:58GLOBESagimet Biosciences Announces Pricing of Public Offering of..
24.1.202412:10EDGAR2Form 8-K - Current report
24.1.202412:08EDGAR2Form S-1/A - General form for registration of securities..
23.1.202423:45GLOBESagimet Biosciences Announces Proposed Public Offering of..
23.1.202423:31EDGAR2Form S-1 - General form for registration of securities under..
22.1.202414:00EDGAR2Form 8-K - Current report
22.1.202413:00GLOBESagimet Biosciences Announces Positive Topline Results from..
29.12.202322:16EDGAR2Form 8-K - Current report
08.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202314:00GLOBESagimet Biosciences to Participate in the First Annual..
28.11.202314:00GLOBESagimet Biosciences Announces Oral Presentation of..
22.11.202314:00GLOBESagimet Biosciences to Present at the 35th Annual Piper..
21.11.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202303:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:40EDGAR2Form 8-K - Current report
13.11.202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:00GLOBESagimet Biosciences Reports Third Quarter 2023 Financial..
10.11.202314:30GLOBESagimet Biosciences Presents Preclinical Results Supporting..
24.10.202317:00GLOBESagimet Biosciences Announces Acceptance of Two Abstracts at..
23.10.202314:00EDGAR2Form 8-K - Current report
18.10.202322:05GLOBESagimet Biosciences To Present at the H.C. Wainwright 7th..
27.9.202322:32EDGAR2Form 8-K - Current report
27.9.202322:05GLOBESagimet Biosciences Announces Completion of Enrollment of..
08.9.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202322:09EDGAR2Form 8-K - Current report
21.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21.8.202322:02GLOBESagimet Biosciences Reports Second Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock